Table 3.4 Reported cases of laboratory-confirmed, chronic hepatitis B virus (HBV) infection, by sex, race/ethnicity, age group, place of birth and case criteria — Emerging Infections Program (EIP) Hepatitis Surveillance Demonstration Sites, 2011

Print
Related Pages
Category
 CO
No. (%)		 CT
No. (%)		 MN
No. (%)		 NM
No. (%)		 NY
State
No. (%)		 NY
City
No. (%)		 OR
No. (%)		 San
Francisco
No. (%)		 Total
No. (%)
Sex
Female
 67
(43.0)		 174
(49.4)		 314
(44.4)		 24
(38.7)		 804
(41.9)		 3174
(45.6)		 195
(45.9)		 444
(48.3)		 5196
(45.2)
Male
 89
(57.1)		 178
(50.6)		 391
(55.2)		 38
(61.3)		 1117
(58.2)		 3779
(54.3)		 229
(53.9)		 475
(51.6)		 6296
(54.7)
Missing
 0
(0.0)		 0
(0.0)		 3
(0.4)		 0
(0.0)		 0
(0.0)		 3
(0.0)		 1
(0.2)		 1
(0.1)		 8
(0.1)
Race/Ethnicity*
AI / AN
 0
(0.0)		 0
(0.0)		 0
(0.0)		 0
(0.0)		 4
(0.2)		 1
(0.0)		 8
(1.9)		 5
(0.5)		 18
(0.2)
API
 55
(35.3)		 141
(40.1)		 246
(34.8)		 34
(54.8)		 577
(30.0)		 1218
(17.5)		 246
(57.9)		 514
(55.9)		 3031
(26.4)
Black
 25
(16.0)		 58
(16.5)		 187
(26.4)		 4
(6.5)		 310
(16.1)		 448
(6.4)		 24
(5.7)		 19
(2.1)		 677
(5.9)
White
 31
(19.9)		 70
(19.9)		 39
(5.5)		 10
(16.1)		 278
(14.5)		 125
(1.8)		 101
(23.8)		 23
(2.5)		 677
(5.9)
Hispanic
 7
(4.5)		 36
(10.2)		 5
(0.7)		 7
(11.3)		 87
(4.5)		 109
(1.6)		 9
(2.1)		 7
(0.8)		 267
(2.3)
Other
 4
(2.6)		 5
(1.4)		 12
(1.7)		 0
(0.0)		 31
(1.6)		 29
(0.4)		 0
(0.0)		 6
(0.7)		 87
(0.8)
Unknown / Missing
 34
(21.8)		 42
(11.9)		 219
(30.9)		 7
(11.3)		 634
(33.0)		 5026
(72.3)		 37
(8.7)		 346
(37.6)		 6345
(55.1)
Age group (yrs)
0-14
 6
(3.9)		 3
(0.9)		 35
(4.9)		 2
(3.2)		 27
(1.4)		 55
(0.8)		 19
(4.5)		 4
(0.4)		 151
(1.3)
15-24
 17
(10.9)		 20
(5.7)		 114
(16.1)		 6
(9.7)		 123
(6.4)		 670
(9.6)		 20
(4.7)		 28
(3.0)		 998
(8.7)
25-39
 67
(43.0)		 154
(33.8)		 291
(41.1)		 15
(24.2)		 553
(28.8)		 2859
(41.1)		 161
(37.9)		 238
(25.9)		 4338
(37.7)
40-54
 44
(28.2)		 103
(29.3)		 169
(23.9)		 22
(35.5)		 735
(38.3)		 2206
(31.7)		 143
(33.7)		 328
(35.7)		 3750
(32.6)
55+
 22
(14.1)		 72
(20.5)		 99
(14.0)		 17
(27.4)		 483
(25.1)		 1166
(16.8)		 82
(19.3)		 322
(35.0)		 2263
(19.7)
Missing
 0
(0.0)		 0
(0.0)		 0
(0.0)		 0
(0.0)		 0
(0.0)		 0
(0.0)		 0
(0.0)		 0
(0.0)		 0
(0.0)
Place of Birth
United States
 14
(9.0)		 40
(11.4)		 25
(3.5)		 U
(U)		 125
(6.5)		 10
(0.1)		 81
(19.1)		 12
(1.3)		 307
(2.7)
Outside US
 77
(49.4)		 147
(41.8)		 218
(30.8)		 U
(U)		 1796
(93.5)		 176
(2.5)		 198
(46.6)		 104
(11.3)		 2981
(25.9)
Missing/
Unknown
 65
(41.7)		 147
(41.8)		 218
(30.8)		 U
(U)		 0
(0.0)		 6770
(97.3)		 146
(34.4)		 804
(87.4)		 8150
(70.9)
Positive Laboratory Tests†
HBV surface antigen
 148
(94.9)		 350
(99.4)		 686
(96.9)		 U
(U)		 1865
(97.1)		 6642
(95.5)		 381
(89.7)		 830
(90.2)		 10902
(94.8)
HBV “e” antigen
 25
(16.0)		 51
(14.5)		 184
(26.0)		 U
(U)		 365
(19.0)		 1379
(19.8)		 83
(19.5)		 117
(12.7)		 2204
(19.2)
HBV-DNA
 64
(41.0)		 131
(37.2)		 464
(65.5)		 U
(U)		 1294
(67.4)		 5487
(78.9)		 163
(38.4)		 629
(68.4)		 8232
(71.6)
Total new
reported cases
 156 352 708 62 1,921 6,956 425 920 11,500
Estimated 2010
population
 5,116,796 3,580,709 5,344,861 2,082,224 11,220,287 8,175,133 3,871,826 812,826 40,274,472
Rate per 100,000 population
 3.0 9.8 13.2 3.0 17.1 84.4 11.0 113.2 28.6

*Categorized in the following order: 1) Hispanic; 2) AI/AN; 3) API; 4) Black; 5) White; 6) Other;
† Cases can be reported with more than one laboratory test result
U=No data available for reporting